Portal de Periódicos da CAPES

Usefulness of [ 11 C]Methionine PET in the Diagnosis of Dysembryoplastic Neuroepithelial Tumor with Temporal Lobe Epilepsy

2003; Wiley; Volume: 45; Issue: 1 Linguagem: Inglês

10.1111/j.0013-9580.2004.20703.x

1528-1167

Taketoshi Maehara, Tadashi Nariai, Nobutaka Arai, Kensuke Kawai, Hiroyuki Shimizu, Kenji Ishii, Kiichi Ishiwata, Kikuo Ohno,

Head and Neck Surgical Oncology

Summary: Purpose: We assessed the diagnostic value of [ 11 C]methionine (MET) positron emission tomography (PET) in the differential diagnosis of dysembryoplastic neuroepithelial tumors (DNETs) among benign tumors associated with temporal lobe epilepsy (TLE). Methods: This series consisted of seven TLE patients with benign tumors in the temporal lobe. After MET‐PET study, all seven patients underwent tumor resection along with focus excision. The uptake of tracers was evaluated by the lesion‐to‐contralateral ratio (L/C ratio) and the standardized uptake value (SUV). We also assessed the relation between MET uptake and proliferation capacity observed in the surgical specimens. Results: Whereas four patients with DNETs did not show high MET uptake visually, the ganglioglioma and gliomas of the remaining three patients were identified as high–MET‐uptake lesions. In the DNETs, the SUV ranged from 1.03 to 1.41, and the L/C ratio ranged from 0.99 to 1.14. MET uptake was significantly lower in the patients with DNETs than in the patients with ganglioglioma and brain gliomas (SUV, p = 0.045; L/C ratio, p = 0.0079). The Ki‐67 labeling index was 4% in one patient with DNET and 5% in one patient with pleomorphic xanthoastrocytoma (higher labeling index). The higher labeling index was not related to high MET uptake based on the SUV (p = 0.91) and L/C ratio (p = 0.38). Conclusions: Negative MET uptake in benign temporal lobe tumors with TLE is consistent with a preoperative diagnosis of DNET.